Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Characterization and immunogenicity of porcine adipose-derived stem cells.

Peng Q., Starch-Jensen T., Kjærgaard B., Fink T.

Animal Study on Chronic Inflammation, published in Res Vet Sci (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Res Vet Sci (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
41202657
DOI
10.1016/j.rvsc.2025.105954

Abstract (original English)

Adipose-derived stem cells (ASCs) hold promise in regenerative medicine due to their multipotent differentiation capacity, anti-inflammatory effects, and ability to promote tissue repair. Porcine models are increasingly used in stem cell research due to their anatomical and physiological similarities to humans. This study aimed to characterize porcine ASCs (pASCs) and evaluate their immunogenicity following allogeneic transplantation. The pASCs were isolated from abdominal subcutaneous adipose tissue of an 18-month-old donor pig, expanded in an automated bioreactor, and cryopreserved. Characterization revealed high expression of mesenchymal markers (CD29, CD44, CD90, CD105) and absence of the hematopoietic marker CD45. The pASCs exhibited robust proliferative and self-renewal capacity, and the ability to differentiate into adipogenic, osteogenic, and chondrogenic lineages. Alloantibody analysis of 18 recipient pigs over four months post-transplantation demonstrated minimal alloantibody formation. These findings confirm mesenchymal stem cell identity and low immunogenicity of large-scale expanded pASCs, supporting their potential application in regenerative medicine. However, further studies are needed to validate the long-term therapeutic efficacy of pASCs in porcine disease models.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsSwineMesenchymal Stem CellsCell DifferentiationAdipose Tissue

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research